Israel Englander Black Diamond Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 226,745 shares of BDTX stock, worth $598,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares

226,745

Previous 50,000 353.49%

Holding current value

$598,606

Previous $233,000 323.18%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.2 - $6.58 $3.27 Million - $5.12 Million	-778,133 Reduced 77.44%	226,745 $986,000
Q2 2024 Aug 14, 2024	BUY	$4.65 - $7.39 $2.13 Million - $3.39 Million	458,641 Added 83.96%	1,004,878 $4.68 Million
Q1 2024 May 15, 2024	BUY	$2.67 - $5.74 $1.13 Million - $2.44 Million	424,428 Added 348.44%	546,237 $2.77 Million
Q4 2023 Feb 14, 2024	SELL	$1.77 - $3.03 $408,639 - $699,536	-230,870 Reduced 65.46%	121,809 $342,000
Q2 2023 Aug 14, 2023	SELL	$1.43 - $6.18 $606,198 - $2.62 Million	-423,915 Reduced 54.59%	352,679 $1.78 Million
Q1 2023 May 15, 2023	BUY	$1.35 - $3.14 $340,249 - $791,396	252,037 Added 48.05%	776,594 $1.47 Million
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.51 $225,522 - $445,718	177,577 Added 51.18%	524,557 $944,000
Q3 2022 Nov 14, 2022	BUY	$1.68 - $4.01 $167,059 - $398,754	99,440 Added 40.17%	346,980 $586,000
Q2 2022 Aug 15, 2022	BUY	$1.5 - $3.63 $371,310 - $898,570	247,540 New	247,540 $609,000
Q1 2022 May 16, 2022	SELL	$2.66 - $5.61 $723,613 - $1.53 Million	-272,035 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.18 - $8.48 $137,363 - $224,872	26,518 Added 10.8%	272,035 $1.45 Million
Q3 2021 Nov 15, 2021	SELL	$8.46 - $12.42 $699,142 - $1.03 Million	-82,641 Reduced 25.18%	245,517 $2.08 Million
Q2 2021 Aug 16, 2021	BUY	$12.19 - $28.17 $2.29 Million - $5.28 Million	187,528 Added 133.35%	328,158 $4 Million
Q1 2021 May 17, 2021	SELL	$22.23 - $34.75 $726,921 - $1.14 Million	-32,700 Reduced 18.87%	140,630 $3.41 Million
Q4 2020 Feb 16, 2021	BUY	$29.47 - $35.0 $3.98 Million - $4.72 Million	134,886 Added 350.86%	173,330 $5.56 Million
Q3 2020 Nov 16, 2020	BUY	$26.17 - $43.07 $640,065 - $1.05 Million	24,458 Added 174.87%	38,444 $1.16 Million
Q2 2020 Aug 14, 2020	BUY	$22.3 - $44.8 $104,587 - $210,112	4,690 Added 50.45%	13,986 $590,000
Q1 2020 May 14, 2020	BUY	$18.18 - $39.48 $169,001 - $367,006	9,296 New	9,296 $232,000

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $95.9M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account